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ABSTRACT: The development of effective protecting group chemistry is an important driving force behind the progress in the
synthesis of complex oligosaccharides. Automated solid-phase synthesis is an attractive technique for the rapid assembly of
oligosaccharides, built up of repetitive elements. The fact that (harsh) reagents are used in excess in multiple reaction cycles
makes this technique extra demanding on the protecting groups used. Here, the synthesis of a set of oligorhamnan fragments is
reported using the cyanopivaloyl (PivCN) ester to ensure effective neighboring group participation during the glycosylation
events. The PivCN group combines the favorable characteristics of the parent pivaloyl (Piv) ester, stability, minimal migratory
aptitude, minimal orthoester formation, while it can be cleaved under mild conditions. We show that the remote CN group in the
PivCN renders the PivCN carbonyl more electropositive and thus susceptible to nucleophilic cleavage. This feature is built upon
in the automated solid-phase assembly of the oligorhamnan fragments. Where the use of a Piv-protected building block failed
because of incomplete cleavage, PivCN-protected synthons performed well and allowed the generation of oligorhamnans, up to
16 monosaccharides in length.
■ INTRODUCTION
The advent of automated solid-phase synthesis approaches for
the assembly of nucleic acids and peptides has transformed the
way chemists generate (fragments of) these biopolymers, and
the rapid access to these molecules has revolutionized the life
sciences. The automated solid-phase synthesis of oligosacchar-
ides is significantly more complex than the assembly of the
other two biopolymers, and as a result, its development has
been significantly slower. Nonetheless, there has been
significant progress in the field of automated solid-phase
oligosaccharide synthesis over the past decade.1,2 A commercial
synthesizer is now available, and there are continuous efforts to
build improved machines.3,4 Ever more complex molecules are
being assembled in an automated manner, and recent highlights
include the assembly of libraries of plant-derived branched
arabino-xylan and xyloglucan structures,5 hyaluronic acid
fragments up to 15 monosaccharides in length,6 a 50-mer
polymannoside,7 a set of dermatan8 and keratan sulfates,9 a set
of α-glucans,10 and a collection of mannuronic acid alginates,
built up to 12 β-mannuronic acid residues linkages.11 These
synthetic successes have shown that linear and branches
structures can be assembled in an automated means and that
both 1,2-trans and 1,2-cis linkages can be reliably installed using
solid-phase chemistry. The method is especially attractive for
the generation of libraries of oligosaccharides and oligosac-
charides featuring repetitive elements.
The key to any successful oligosaccharide synthesis campaign
is the protection group strategy used. Permanent protecting
groups should be able to withstand all conditions used
throughout the assembly route, while temporary protecting
groups have to be removed selectively without touching any
other functionalities in the molecule. The requirements for
protecting groups in automated solid-phase oligosaccharide
synthesis are even more strenuous as they have to withstand
glycosylation and deprotection steps repeatedly, under
conditions harsher than those used in traditional solution-
phase experiments, because often an excess of reagents is used
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to drive reactions to completion. The introduction of new
protecting groups and protecting group chemistry will be
crucial for the further development of automated solid-phase
oligosaccharide synthesis.
We introduced the cyanopivaloyl (PivCN) group as an
attractive participating group that allows for the reliable
construction of 1,2-trans-glycosidic linkages.12 It features the
favorable characteristics of the pivaloyl esterstability, effective
neighboring group participation, minimal othoester formation,
and migratory aptitudewhile it circumvents the drawbacks of
the parent pivaloyl groupits problematic removal at the end
of the synthesisas it can be removed by reduction of the
cyano group to the corresponding amine, which can engage in
an effective intramolecular ring closure to cleave the ester
function. Thus, removal of the cyanopivaloyl group can be
effected in tandem with the removal of benzyl ethers,
commonly used as permanent protecting groups.
These favorable characteristics should make the cyanopiva-
loyl group an attractive protecting group to be used in
automated synthesis. To probe its effectiveness in an automated
solid-phase setting, we explored its use in the assembly of a set
of oligorhamnosides, up to 16 monosaccharides in length (see
Figure 1). These target structures represent fragments of the
backbone of the cell wall polysaccharide of group A
Streptococcus (GAS), a Gram-positive bacterium, which is the
cause of various infections (pharyngitidis, necrotizing fasciitis)
and which is found responsible for rheumatic fever, causing
hundreds of thousands of deaths every year in developing
countries.13,14 The GAS polyrhamnose backbone is decorated
with N-acetyl glucosamine appendages at the rhamnosyl C-3
hydroxyl.15 The potential use of this naturally occurring
polysaccharide in conjugate vaccines may be thwarted by the
potentially autoimmunogenic GlcNAc epitopes, and it has been
suggested that the nonmammalian “bare” polyrhamnose
backbone, devoid of GlcNAc groups, may be an attractive
structure for a GAS vaccine. Well-defined fragments of the
polyrhamnose backbone will be valuable in the generation of
semisynthetic vaccines and therefore represent attractive
synthetic targets.16−22 The repetitive nature of these molecules
makes them very well suited for an automated synthesis
approach.
■ RESULTS AND DISCUSSION
The synthetic strategy and test case for the cyanopivaloyl group
for the assembly of the oligorhamnosides are depicted in
Scheme 1. In this study, a commerical Glyconeer 2.1
synthesizer was used for the automated assembly. The
oligosaccharides are built on a polystyrene resin equipped
with a linker system23 that provides the target structures with
an aminopentanol spacer after global deprotection. The amine
in the linker system is protected with a benzyl and a modified
Cbz protecting group. The Cbz part is connected to the solid
support via a base-labile ester linkage. Disaccharide building
blocks were used in this study bearing an imidate as anomeric
leaving group and a levulinoyl group as orthogonal temporary
group, as these functionalities have proven very effective in
various previous automated solid-phase assembly proce-
Figure 1. Synthetic approach described in this work.
Scheme 1. Generation of the Linker-Equipped Resina
aReagents and conditions: (a) TBDMS-Cl, imidazole, DMF, 0 °C (30%); (b) para-nitrophenylchloroformate, pyridine, 0 °C; (c) N-benzyl-5-
aminopentanol, DIPEA, DMF, 0 °C (90%); (d) (i) DMTr-Cl, pyridine, 0 °C; (ii) TBAF, THF, 0 °C (100%); (e) TMSCHN2, MeOH, THF; (f) 11,
DIC, DMAP, DCM, then MeOH; (g) TCA, DCM.
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dures.6,11 Dimer donors were to be used because acyl groups at
the axial C-2 hydroxyl of rhamnosides are prone to migrate to
the equatorial C-3 hydroxyl group when this functionality is
unmasked during the synthesis. Partial migration of protecting
groups will lead to complex and inseparable mixtures after
several coupling rounds. Two different dimer building blocks
were explored: the first (dimer 1) carrying a permanent pivaloyl
ester at the C-2 hydroxyl and the second (building block 2)
with a cyanopivaloyl at this position.
The linker-functionalized resin 3 is obtained in seven steps
from 1,4-benzenedimethanol, following an improved route of
synthesis, originally developed by Czechura et al., as depicted in
Scheme 1.23 After silylation of one hydroxyl group (30% yield),
the remaining hydroxyl is transformed into an active carbonate
by reaction of compound 9 with para-nitrophenylchlorofor-
mate and reacted with N-benzyl-5-aminopentanol to yield
compound 10. Installation of the dimethoxytrityl group
proceeded uneventfully, but because purification of the fully
protected linked system from excess reagent proved trouble-
some, the TBS group was directly removed. Compound 11 was
obtained pure in quantitative yield over two steps on 16 mmol
scale.
Next, the linker was conjugated to the carboxylic-acid-
functionalized polystyrene resin. Because the loading of the
commercially available resin was too high (2.19 mmol/g), the
amount of carboxylic acid groups was first reduced by treatment
of the resin with TMS-diazomethane.24,25 Afterward, the
resulting resin was coupled with the DMT-protected linker.
Removal of the DMTr group was achieved by a TCA/DCM
Scheme 2. Synthesis of Donors 1 and 2a
aReagents and conditions: (a) 14, TfOH, DCM, 0 °C (17, 69%, 18, 88%); (b) NBS, acetone/H2O (19, 65%, 20, 89%), then ClC(NPh)CF3,
Cs2CO3, acetone, 0 °C (1, 88%, 2, 79%); (c) NIS, TFA, DCM, 0 °C (20a, 73%), then ClC(NPh)CF3, Cs2CO3, acetone, 0 °C (2, 79%).
Scheme 3. Automated Synthesis of Decamers 21 and 22 and Hexadecamer 23a
aReagents and conditions: (a) 3 equiv of 1 or 2, 0.3 equiv of TfOH, DCM, 0 °C, 3 cycles; (b) 8 equiv of H2NNH2·AcOH, pyr/AcOH, 40 °C, 3
cycles; (c) NaOMe, MeOH/THF; (d) NaOMe, MeOH/THF (25, 9%, 26, 26%, 27, 6%, 28, 9%, 29, 9% starting from resin 3); (e) NaOH (aq),
MeOH/dioxane, 40 °C; (f) H2, Pd(OH2)/C, AcOH, H2O/THF/tBuOH (4, 69%, 5, 57%, 6, 27%, 7, 92%, 8, 50%).
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treatment, after which the loading was determined to be 0.44−
0.47 mmol/g.
The synthesis of the required dirhamnosyl building blocks is
depicted in Scheme 2 and started by coupling imidate donor
1412 and acceptor 1526/1612 using a catalytic amount of TfOH.
This led to disaccharides 17 and 18, which could both be
purified by crystallization from hot ethanol. The thioglycosides
17/18 were transformed into the corresponding imidate donors
by treatment with N-bromosuccinimide in acetone/water21 and
subsequent installation of the N-phenyl trifluoroacetimidoyl
functionality.27
With the required building blocks in hand, the assembly of
the oligosaccharides was started. As a first research objective,
the assembly of a decasaccharide was targeted, employing the
pivaloyl-protected building block 1. Previously developed
glycosylation and deprotection conditions6,11 were applied to
couple donor 1 to resin 3 (3 × 3 equiv of donor, 0.2 equiv of
TfOH with respect to the donor, 30 min at 0 °C, Scheme 3),
followed by removal of the Lev group (3 × 5 equiv of
H2NNH2·AcOH, 10 min at 40 °C). After five coupling/
deprotection cycles, the resin was subjected to cleavage
conditions (a catalytic amount of NaOMe in a mixture of
THF/MeOH).
The crude decasaccharide 21 was analyzed by LC-MS, and
the obtained LC-spectrum is shown in Figure 2. A complex
mixture was obtained, which was the result of incomplete
glycosylation reactions and removal of some of the pivaloyl
esters. Unfortunately, it proved to be impossible to remove all
pivaloyl esters, even under harsh basic conditions (NaOH in
MeOH/dioxane at elevated temperature (conditions e, Scheme
3),28 and the desired decasaccharide could not be obtained
from the complex reaction mixture (Figure 2B). The use of
pivaloyl-funtionalized donor 1 was therefore not further
explored, and attention was switched to the use of its PivCN
counterpart 2.
When donor 2 was used for the assembly of decasaccharide
22, again a complex product mixture arose after cleavage of the
products from the resin (Figure 2C).29 It was noted, however,
that a significantly larger portion of the PivCN groups had been
removed from the target structures in comparison to the
pivaloyl decasaccharide mixture. This indicates that the cyano
group in the PivCN ester renders the ester carbonyl more
electrophilic, as a result of its electron-withdrawing character,
even though it is separated from the carbonyl by two carbon
atoms.30 This also suggested that the PivCN groups could
potentially be removed by an additional and/or elongated base
Figure 2. LC chromatogram of the crude products cleaved from the resin before and after prolonged base treatment: (A) 21; (B) 24; (C) 22; (D)
26; (E) 23; (F) 29. Reagents and conditions: (A) diphenyl column, 50→ 90% B; (B) diphenyl column, 50→ 90% B; (C) C4 column, 50→ 90% B;
(D) C4 column, 50 → 90% B; (E) diphenyl column, 50 → 98% B; (F) diphenyl column, 50 → 98% B.
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treatment. To explore this possibility, the crude mixture was
resubjected to basic conditions, and progress of the reaction
was monitored by LC-MS. The LC chromatogram of the
mixture that was finally obtained is shown in Figure 2D, and it
shows the presence of only two products. The major product in
the mixture proved to be the desired decasaccharide 26,
whereas the other minor peak corresponds to the octasacchar-
ide (25). Purification of the target compound was readily
achieved from this mixture, and the target decasaccharide was
obtained in 26% overall yield after 12 steps (89% per step).
Driven by this success, a hexadecasaccharide was synthesized
by running eight coupling/deprotection cycles using donor 2.
After cleavage of the products from the resin, a complex
mixture was obtained (Figure 2E). Subjection of this mixture to
an additional base treatment led to complete cleavage of all
PivCN groups, and Figure 2F depicts the LC chromatogram of
the resulting mixture. From this mixture, the target
hexadecarhamnoside 29 was obtained in 9% yield (18 steps,
87% per step) alongside the dodeca- and tetradecasaccharide
deletion sequences, 27 and 28, respectively.
To complete the syntheses of the oligorhamnosides, all
obtained partially protected oligorhamnosides (25−29) were
subjected to hydrogenolysis over Pd(OH)2/C in H2O/THF/
tBuOH to remove all benzyl groups and liberate the alcohols
and the amine functionality on the spacer. Gel filtration
(HW40, eluted with NH4OAc) yielded the fully deprotected
octa-, deca-, dodeca-, tetradeca-, and hexadecasaccharides (4−
8) in multimilligram quantities.
■ CONCLUSION
We have introduced the cyanopivaloyl (PivCN) ester as an
effective protecting group for solid-phase oligosaccharide
synthesis. This novel protecting group was probed in the
assembly of a series of oligorhamnosides, alongside its pivaloyl
counterpart. It was found that cleavage of the protected
oligosaccharides from the resin was accompanied by partial
cleavage of the pivaloyl groups. Complete removal of all
pivaloyl groups, however, proved to be difficult, underscoring
the problems often encountered with this bulky ester. The
cyanopivaloyl ester on the other hand could be effectively
cleaved under basic conditions, as a result of the remote
electron-withdrawing cyano group, which renders the ester
carbonyl group more electrophilic. The favorable cleavage
characteristics of the PivCN group in combination with the
favorable properties of the pivaloyl-type esters (minimal
orthoester formation during glycosylations, minimal migration,
stability) make the PivCN group an attractive asset in the
toolbox of the synthetic chemist. Here, it has proven its merits
in the automated solid-phase assembly of GAS-related
oligorhamnosides of considerable length.
■ EXPERIMENTAL SECTION
General Experimental Procedures. All solvents used under
anhydrous conditions were stored over 4 Å molecular sieves except for
methanol, which was stored over 3 Å molecular sieves. 1H and 13C
NMR spectra were recorded on a 400/100, 500/125, 600/150, or a
850/214 MHz spectrometer. Chemical shifts (δ) are given in parts per
million relative to tetramethylsilane as internal standard. Coupling
constants are given in hertz. All individual signals were assigned using
2D NMR spectroscopy, HH−COSY, HSQC, and HMBC. IR spectra
are reported in cm−1 and recorded on a Shimadzu FTIR-8300 or a
PerkinElmer universal attenuated total reflectance (UATR; single
reflection diamond) Spectrum Two instrument. Solvents used for
workup and column chromatography were of technical grade from
Sigma-Aldrich, Boom, Biosolve, or Honeywell and used directly.
Unless stated otherwise, solvents were removed by rotary evaporation
under reduced pressure at 40 °C. All chemicals were used as received
unless stated otherwise. Reactions were monitored by TLC analysis
using Merck 25 DC plastikfolien 60 F254 with detection by spraying
with 20% H2SO4 in EtOH, (NH4)6Mo7O24·4H2O (25 g/L), and
(NH4)4Ce(SO4)4·2H2O (10 g/L) in 10% sulfuric acid, by spraying
with a solution of ninhydrin (3 g/L) in EtOH/AcOH (20/1 v/v), or
by dipping in anisaldehyde (10 mL in 180 mL EtOH/10 mL H2SO4)
followed by charring at approximately 150 °C. Column chromatog-
raphy was performed on Fluka silica gel (0.04−0.063 mm). For LC-
MS analysis, an Agilent Technologies 1260 Infinity LC system
(detection simultaneously at 214 and 254 nm) coupled to a Agilent
Technologies 6120 Quadrupole LC/MS, using an analytical Vydac C4
column (Alltech, 50 × 4.60 mm, 5 μm) or a Vydac Diphenyl (Alltech,
150 × 4.60 mm, 5 μm) in combination eluents A (H2O), (B) MeCN,
and (C) 1% aqueous TFA. For HPLC, a Gilson HPLC system in
combination with eluents A (H2O, 0.1% TFA) and B (MeCN as the
solvent system using a Vydac C4 HPLC column; Grace, 250 × 10 mm,
5 μm). High-resolution mass spectra were recorded by direct injection
(2 μL of a 2 μM solution in water/acetonitrile; 50/50; v/v and 0.1%
formic acid) on a mass spectrometer (Thermo Finnigan LTQ
Orbitrap) equipped with an electrospray ion source in positive
mode (source voltage 3.5 kV, sheath gas flow 10, capillary temperature
250 °C) with resolution R = 60000 at m/z 400 (mass range m/z =
150−2000) and dioctyl phthalate (m/z = 391.2842) as a “lock mass”.
The high-resolution mass spectrometer was calibrated prior to
measurements with a calibration mixture (Thermo Finnigan).
MALDI spectra were recorded on an Ultraflextreme MALDI-TOF
(Bruker Daltonics), equipped with Smartbeam-II laser, to measure the
samples in reflectron positive ion mode. The MALDI-TOF was
calibrated using a peptide calibration standard prior to measurement.
One microliter of 2,5-dihydroxybenzoic acid (Bruker Daltonics) matrix
(20 mg/mL in ACN/water; 50:50 (v/v)) was applied on a 384-MTP
target plate (Bruker Daltonics, Bremen, Germany) and air-dried.
Subsequently, 1 μL of compound water solution was spotted on the
plate, and the spots were left to dry prior to MALDI-TOF analysis.
(4-tert-Butyldimethylsiloxylmethylphenyl)methanol (9). 1,4-
Benzenedimethanol (8.29 g, 60 mmol, 1.0 equiv) was dissolved in 25
mL of DMF and cooled to 0 °C followed by the addition of imidazole
(10.2 g, 150 mmol, 2.5 equiv). A solution of tert-butyldimethylsilyl
chloride (9.13 g, 60.6 mmol, 1.01 equiv) in 40 mL of DMF was added
dropwise, and the reaction was allowed to stir overnight. After TLC
analysis showed complete consumption of the starting material, the
mixture was diluted with Et2O and washed subsequently with H2O
(2×) and saturated aqueous NaCl (1×). The organic phase was dried
over MgSO4 and concentrated in vacuo. Purification using flash
column chromatography (PE/EtOAc, 9:1 → 6:1) yielded the title
compound as a colorless oil (4.73 g, 18.7 mmol, 30%): Rf 0.39 (PE/
EtOAc, 6/1, v/v); 1H NMR (400 MHz, CDCl3) δ 7.33 (s, 4H), 4.74
(s, 2H), 4.68 (d, 2H, J = 3.1 Hz), 1.67−1.50 (m, 2H), 0.94 (s, 9H),
0.10 (s, 6H). Analytical data are identical to literature values.31
N-Benzyl-5-aminopentanol. Benzaldehyde (10.67 mL, 104.6
mmol, 1.01 equiv) was added to a solution of 5-aminopentalnol (11.3
mL, 104.0 mmol, 1.0 equiv) in 150 mL of EtOH. The solution was
heated to 50 °C under reduced pressure until all solvent was removed.
The crude mixture was coevaporated twice with anhydrous toluene,
dissolved in MeOH (200 mL), and cooled to 0 °C. NaBH4 (4.82 g,
124.7 mmol, 1.2 equiv) was added in portions, and the solution was
allowed to stir at 0 °C for 70 min. After being stirred for another 2 h,
the solution was cooled to 0 °C followed by addition of 4.5 mL of
AcOH. A 1.2 M K2CO3 (aq) solution (135 mL) was added, and the
mixture was diluted with Et2O. The organic layer was dried over
MgSO4 and concentrated in vacuo. Purification using flash column
chromatography yielded the linker in 62% yield (12.4 g, 64 mmol): 1H
NMR (400 MHz, CDCl3) δ 7.41−7.15 (m, 5H), 3.78 (s, 2H), 3.62 (t,
2H, J = 6.4, 6.4 Hz), 2.64 (t, 2H, J = 7.0, 7.0 Hz), 1.92 (s, 2H), 1.72−
1.47 (m, 4H), 1.47−1.25 (m, 2H); 13C NMR (101 MHz, CDCl3) δ
140.2, 128.5, 128.3, 127.1, 62.7, 54.1, 49.3, 42.0, 32.6, 29.7, 29.1, 23.5.
Analytical data are identical to literature values.32
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5-(Benzyl(4-tert-butyldimethylsilyl)oxymethylbenzyloxy-
carbonyl)amino)pentanol (10). Silylether 9 (4.73 g, 18.7 mmol, 1.0
equiv) was dissolved in dry DCM (125 mL) and cooled to 0 °C.
Pyridine (3.0 mL, 37.5 mmol, 2.0 equiv) was added followed by
addition of para-nitrophenylchloroformate (4.53 g, 22.5 mmol, 1.2
equiv), after which the solution was allowed to warm to RT and stirred
overnight. The reaction was concentrated in vacuo and coevaporated
with toluene. The crude compound was dissolved in DMF (75 mL)
and cooled to 0 °C. To this mixture was added N-benzyl-5-
aminopentanol (4.78 g, 23.0 mmol, 1.23 equiv) in DMF (20 mL)
followed by addition of DIPEA (4.23 mL, 24.4 mmol, 1.3 equiv) The
reaction mixture was stirred overnight, diluted with Et2O, and washed
with H2O. The aqueous layer was back extracted with Et2O, and the
combined organic layers were washed multiple times with saturated
aqueous NaHCO3. The solution was dried over MgSO4, filtered, and
concentrated in vacuo. Column purification (PE/EtOAc, 8:1 → 3:1)
yielded the title compound (8.02 g, 17.0 mmol, 90%): IR (neat) 1083,
1249, 1417, 1454, 1681, 1695, 2856, 2929, 2949, 3062, 3387, 3437
cm−1; 1H NMR (500 MHz, CDCl3) δ 7.21−7.10 (m, 9H, CHarom),
5.06 (s, 2H, CH2 Cbz), 4.63 (s, 2H, CH2 Bn), 4.39 (s, 2H, CH2 Cbz),
3.46 (s, 2H, CH2), 3.15 (s, 2H, CH2), 1.41−1.20 (s, 6H, 3 × CH2),
0.85 (s, 9H, 3 × CH3 TBDMS), 0.00 (s, 6H, 2 × CH3 TBDMS);
13C
NMR (126 MHz, CDCl3) δ 141.5, 138.3, 135.7 (Cq), 128.7, 128.1,
127.5, 126.4 (CHarom), 67.3 (CH2), 65.0 (CH2), 62.9 (CH2), 50.7
(CH2), 32.6 (CH2), 26.1 (3 × CH3 TDBDMS), 23.2 (CH2), −5.1 (2
× CH3 TBDMS); HRMS [M + H]
+ calcd for C27H42NO4Si 472.2878,
found 472.2877.
5-(Benzyl(4-hydroxymethylbenzyloxycarbonyl)amino)-
pentyldimethoxytrityl ether (11). Silylether 10 (7.50 g, 15.9 mmol,
1.0 equiv) was coevaporated twice with pyridine under an argon
atmosphere, before being dissolved in pyridine (160 mL) and cooled
to 0 °C. To the mixture was added DMTr-Cl (5.92 g, 17.5 mmol, 1.1
equiv), and it was allowed to stir overnight. After being stirred
overnight, TLC analysis (hexanes/EtOAc, 4:1) showed conversion of
the starting material to a high running spot. The mixture was
concentrated, dissolved in EtOAc and washed twice with H2O, dried
over MgSO4, and concentrated in vacuo. The intermediate was
coevaporated with toluene, dissolved in THF (160 mL), and cooled to
0 °C. TBAF (1.0 M in THF, 25 mL, 1.6 equiv) was added, and the
green colored reaction was stirred for 5 h, after which it was
concentrated. The compound was dissolved in EtOAc, washed
subsequently with H2O, saturated aqueous NaHCO3, and saturated
aqueous NaCl. The organic layer was dried over MgSO4 and
concentrated in vacuo. Purification by column chromatography
(Tol/EtOAc + Et3N, 9:1 → 4:1) yielded DMTr-protected linker
(10.2 g, 15.9 mmol, 100%): IR (neat) 1031, 1246, 1300, 1417, 1506,
1606, 1693, 2835, 2864, 2931, 3030, 3059, 3415, 3441 cm−1; 1H NMR
(400 MHz, CDCl3, T = 328 K) δ 7.41 (d, J = 7.6 Hz, 2H, CHarom),
7.35−7.07 (m, 16H, CHarom), 6.80 (d, J = 8.5 Hz, 4H, CHarom), 5.13
(s, 2H, CH2 Cbz), 4.63 (s, 2H, CH2 Bn), 4.46 (s, 2H, CH2 Cbz), 3.76
(s, 6H, 2 × CH3 OMe), 3.21 (s, 2H, CH2), 3.02 (s, 2H, CH2), 1.69−
1.24 (m, 6H, 3 × CH2);
13C NMR (101 MHz, CDCl3) δ 158.6, 145.6,
140.9, 136.9 (Cq), 130.2, 128.6, 128.4, 128.2, 127.8, 127.4, 127.1,
126.7, 113.2 (CHarom), 67.1 (CH2), 65.1 (CH2), 63.4 (CH2), 55.3
(OMe), 29.9 (CH2), 23.8 (CH2); HRMS [M + Na]
+ calcd for
C42H45NO6Na 682.3139, found 682.3139.
Synthesis of Aminopentanol-Functionalized Polystyrene
(12).
Carboxy polystyrene (Rapp polymer, 5 g, 2.19 mmol/g, 11 mmol) was
added to a fritted syringe and swollen in 32 mL of DCM. The resin
was purged with argon, after which it was washed with DCM (3×),
alternating DCM and hexane (3×), and DCM (2×). The resin was
dried in vacuo at 45 °C overnight. The dried resin was suspended in
60 mL of THF, and MeOH (1.03 mL, 25.4 mmol, 3 equiv with respect
to Me3SiCHN2) was added. The suspension was shaken for 10 min
followed by addition of Me3SiCHN2 (4.24 mL of 2.0 M solution in
hexanes, 8.47 mmol, 0.77 equiv with respect to the resin), whereupon
the solution turned yellow. The reaction was allowed to shake
overnight, after which it became colorless. The solution was filtered,
and resin 12 was washed with DCM (4×), hexanes (4×), and THF
(4×) and dried in vacuo at 45 °C.
Carboxy polystyrene 12 (Rapp polymer, 5 g, ∼0.51 mmol/g, 2.54
mmol) was swollen in DCM (60 mL), and the suspension was shaken
for 1 h. The solution was filtered, and DCM (40 mL) was added to the
resin. Compound 11 (5.04 g, 7.64 mmol, 3 equiv) was coevaporated
twice with toluene under argon, dissolved in DCM (8.5 mL), with
addition of DIC (1.20 mL, 7.64 mmol, 3 equiv) and DMAP (0.03 g,
0.25 mmol, 0.1 equiv). An additional rinse with 5 mL of DCM was
performed before the resin was allowed to shake overnight. Then,
MeOH (0.6 mL) was added, and the suspension was shaken again.
The mixture was filtered, and resin 13 was washed with alternating
DCM and hexanes (4×), followed by DCM (3×). The resin was dried
in vacuo at 45 °C.
Solid Support (3). DMT-functionalized resin 13 (5 g) was loaded
into a fritted funnel and washed with 3% TCA (w/v in DCM, 60 mL)
and shaken for 5 min. The orange solution was filtered, and the
procedure was repeated 4×. After the TCA washes, the orange resin
was washed 3× with DCM (60 mL), 3× with toluene (60 mL), 3×
with DCM/MeOH (60 mL), 1× with MeOH (60 mL), and 4× DCM
(60 mL). The resin was dried in vacuo to a constant weight of 4.22 g.
DMTr Assay (Performed in Duplicate). DMT-functionalized
resin 13 (4.1 mg) was added to a 10 mL volumetric flask and treated
with 10 mL of 3% TCA/DCM (w/v). A 1 mL aliquot was taken and
diluted 100× with the 3% TCA/DCM solution. Absorbance read at λ
= 503 nm.
=
× =
=
μ
= μ
= × =
= =
⎜ ⎟
⎛
⎝⎜
⎞
⎠⎟
⎛
⎝
⎞
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A
Loading calculation:
[( )(100 mL)]
76
mmol in final solution
mmol in final solution
volume aliquot
10 mL mmol in initial solution
(0.137)(100 mL)
76 mL/ mol
0.180 mol
0.00018 mmol
1 mL
10 mL 0.00180mmol
loading
0.00180 mmol
0.0041 g
0.44 mmol/g
503
A loading of 0.44−0.47 mmol/g was determined.
Phenyl 4-O-Benzyl-2-O-pivaloyl-3-O-(3,4-di-O-benzyl-2-O-
levulinoyl-α-L-rhamnopyranosyl)-1-thio-α-L-rhamnopyrano-
side (17). Compound 1526 (4.96 g, 11.52 mmol, 1.0 equiv) and
imidate donor 14 (7.56 g, 13.32 mmol, 1.2 equiv) were coevaporated
twice with anhydrous toluene under an argon atmosphere, after which
they were dissolved in dry DCM (56 mL). The mixture was stirred on
activated molecular sieves for 20 min at RT and then cooled to 0 °C.
TfOH (0.1 mL, 1.12 mmol, 0.1 equiv) was added, and after 135 min,
TLC analysis showed complete consumption of the acceptor, and the
reaction was quenched by addition of 0.3 mL of Et3N. The mixture
was diluted with EtOAc, washed subsequently with saturated aqueous
NaHCO3 and saturated aqueous NaCl, dried over MgSO4, and
concentrated in vacuo. Crystallization from hot EtOH (5.65 g, 6.61
mmol), followed by a second crystallization of the mother liquid,
yielded the disaccharide as white crystals (6.65 g, 7.78 mmol, 69%):
mp 145 °C; Rf 0.69 (PE/EtOAc, 2/1, v/v); IR (neat) 918, 987, 1026,
1039, 1060, 1082, 1138, 1454, 1479, 1732, 2873, 2910, 2933, 2974
cm−1; 1H NMR (500 MHz, CDCl3) δ 7.47−7.41 (m, 2H, CHarom),
7.36 (d, J = 4.4 Hz, 4H, CHarom), 7.37−7.16 (m, 13H, CHarom), 5.39
(dd, J = 3.3, 1.8 Hz, 1H, H-2′), 5.35 (d, J = 1.8 Hz, 1H, H-1), 5.29 (dd,
J = 3.2, 1.8 Hz, 1H, H-2), 5.06 (d, J = 1.9 Hz, 1H, H-1′), 4.91 (d, J =
11.5 Hz, 1H, CHH Bn), 4.78 (d, J = 10.8 Hz, 1H, CHH Bn), 4.67−
4.54 (m, 3H, CHH, CH2 Bn), 4.46 (d, J = 11.5 Hz, 1H, CHH Bn),
4.26−4.16 (m, 1H, H-5), 4.11 (dd, J = 9.4, 3.1 Hz, 1H, H-3), 3.81 (dd,
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J = 9.3, 3.4 Hz, 1H, H-3′), 3.73−3.64 (m, 1H, H-5′), 3.49 (t, J = 9.5
Hz, 1H, H-4), 3.41 (t, J = 9.4 Hz, 1H, H-4′), 2.69−2.65 (m, 4H, 2 ×
CH2 Lev), 2.13 (s, 3H, CH3 Lev), 1.33−1.22 (m, 6H, 2 × CH3-6),
1.20 (s, 9H, 3 × CH3 Piv);
13C NMR (126 MHz, CDCl3) δ 206.0
(CO Lev), 177.3, 171.8 (CO Lev, Piv), 138.7, 137.8, 137.7, 133.6
(Cq), 132.1, 129.0, 128.5, 128.4, 128.3, 128.2, 127.9, 127.7, 127.6,
127.5, 127.4 (CHarom), 99.7 (C-1′), 85.6 (C-1), 80.4 (C-4), 79.6 (C-
4′), 77.7 (C-3), 77.2 (C-3′), 75.5 (CH2 Bn), 74.8 (CH2 Bn), 73.6 (C-
2), 71.5 (CH2 Bn), 69.3 (C-5), 69.1 (C-2′), 68.5 (C-5′), 39.0 (Cq
Piv), 38.0 (CH2 Lev), 29.8 (CH3 Lev), 28.1 (CH2 Lev), 27.1 (CH3
Piv), 17.9 (C-6), 17.8 (C-6′); HRMS [M + H]+ calcd for
C49H62NO11S 872.4038, found 872.4045.
4-O-Benzyl-2-O-pivaloyl-3-O-(3,4-di-O-benzyl-2-O-levulino-
yl-α-L-rhamnopyranosyl)-α/β-L-rhamnopyranoside (19). Com-
pound 17 (2.76 g, 3.23 mmol, 1.0 equiv) was dissolved in acetone/
H2O (3:1, 16 mL) and cooled to 0 °C. NBS (1.73 g, 9.69 mmol, 3.0
equiv) was added, and the reaction was stirred overnight. TLC analysis
showed conversion of the starting material to a lower running spot and
the mixture was quenched with saturated aqueous Na2S2O3. The
mixture was diluted with EtOAc, and the organic layer was washed
with saturated aqueous NaHCO3, dried over MgSO4, and concen-
trated in vacuo. Purification by column chromatography (PE/EtOAc,
4:1 → 1:1) yielded the title hemiacetal (1.60 g, 2.10 mmol, 65%).
Spectroscopic data are reported for the major (α) isomer: Rf 0.26 (PE/
EtOAc, 2/1, v/v); IR (neat) 1064, 1082, 1134, 1163, 1363, 1708,
1776, 2875, 2933, 2974, 3381 cm−1; 1H NMR (500 MHz, CDCl3) δ
7.39−7.15 (m, 15H, CHarom), 5.36 (dd, J = 3.1, 1.8 Hz, 1H, H-2′),
5.05−4.99 (m, 3H, H-1, H-1′, H-2), 4.90 (d, J = 11.4 Hz, 1H, CHH
Bn), 4.74 (d, J = 10.8 Hz, 1H, CHH Bn), 4.66−4.51 (m, 3H, CHH Bn,
CH2 Bn), 4.43 (d, J = 11.5 Hz, 1H, CHH Bn), 4.16 (dd, J = 9.5, 3.0
Hz, 1H, H-3′), 3.97−3.87 (m, 1H, H-5), 3.79 (dd, J = 9.3, 3.3 Hz, 1H,
H-3), 3.71−3.62 (m, 1H, H-5′), 3.48 (s, 1H, OH), 3.38 (dt, J = 9.4, 6.7
Hz, 2H, H-4, H-4′), 2.73−2.60 (m, 4H, 2 × CH2 Lev), 2.15 (s, 3H,
CH3 Lev), 1.29−1.17 (m, 15H, 2 × CH3 C-6, C-6′, 3 × CH3 Piv); 13C
NMR (126 MHz, CDCl3) δ 206.5 (CO Lev), 177.7, 171.9 (CO
Lev, Piv), 138.8, 138.8, 137.9, 137.9 (Cq), 128.6, 128.5, 128.4, 128.4,
128.3, 128.3, 128.3, 128.1, 128.0, 128.0, 127.8, 127.7, 127.6, 127.6,
127.5 (CHarom), 99.7 (C-1′), 91.7 (C-1), 80.4, 79.7 (C-4, C-4′), 77.3
(C-3′), 77.1 (C-3), 75.5 (CH2 Bn), 74.9 (CH2 Bn), 72.5 (C-2), 71.6
(CH2 Bn), 69.4 (C-2′), 68.4, 67.7 (C-5, C-5′), 39.0 (Cq), 38.1 (CH2
Lev), 29.9 (CH3 Lev), 28.2 (CH2 Lev), 27.2 (3 × CH3 Piv), 18.2, 17.9
(2 × CH3 C-6, C-6′); HRMS [M + Na]+ calcd for C43H54O12Na
785.3508, found 785.3511.
4-O-Benzyl-2-O-pivaloyl-3-O-(3,4-di-O-benzyl-2-O-levulino-
yl-α-L-rhamnopyranosyl)-1-(N-phenyltrifluoroacetimidoyl)-α/
β-L-rhamnopyranoside (1). To a solution of hemiacetal 19 (1.66 g,
2.18 mmol, 1.0 equiv) in acetone (11 mL) at 0 °C were added N-
phenyltrifluoroacetimidoyl chloride (0.41 mL, 2.62 mmol, 1.2 equiv)
followed by Cs2CO3 (1.07 g, 3.27 mmol, 1.5 equiv). The solution was
allowed to stir for 3 h, after which it was filtered over Celite and
concentrated in vacuo. Purification by column chromatography (PE/
EtOAc, 6:1 → 2:1) yielded the title compound as a clear yellow oil
(1.81 g, 4.15 mmol, 88%). Spectroscopic data are reported for the
major (α) isomer: Rf 0.67 (PE/EtOAc, 2/1, v/v); IR (neat) 989, 1028,
1116, 1138, 1207, 1454, 1597, 1716, 1737, 2908, 2976 cm−1; 1H NMR
(400 MHz, CDCl3) δ 7.49−7.22 (m, 17H, CHarom), 7.08 (t, J = 7.5 Hz,
1H, CHarom), 6.81 (d, J = 7.7 Hz, 2H, CHarom), 6.08 (s, 1H, H-1), 5.39
(dd, J = 3.0, 1.8 Hz, 1H, H-2′), 5.22 (s, 1H, H-2), 5.07 (s, 1H, H-1′),
4.92 (d, J = 11.4 Hz, 1H, CHH Bn), 4.77 (d, J = 10.7 Hz, 1H, CHH
Bn), 4.69−4.54 (m, 3H, CHH Bn, CH2 Bn), 4.47 (d, J = 11.5 Hz, 1H,
CHH Bn), 4.22−4.15 (m, 1H, H-3), 3.90−3.75 (m, 2H, H-5, H-3′),
3.75−3.63 (m, 1H, H-5′), 3.49 (t, J = 9.5 Hz, 1H, H-4), 3.41 (t, J = 9.3
Hz, 1H, H-4′), 2.75−2.60 (m, 4H, 2 × CH2 Lev), 2.15 (s, 3H, CH3
Lev), 1.39−1.11 (m, 15H, 2 × CH3 C-6, C-6′, 3 × CH3 Piv); 13C
NMR (101 MHz, CDCl3) δ 206.2 (CO Lev), 177.3, 171.9 (CO
Lev, Piv), 143.4, 138.8, 137.9, 137.5 (Cq), 128.8, 128.6, 128.5, 128.4,
128.3, 128.2, 128.1, 127.8, 127.6, 127.5, 124.5, 119.4 (CHarom), 99.8
(C-1′), 79.7 (C-4′), 77.3 (C-3), 76.6 (C-3′), 75.8 (CH2 Bn), 74.9
(CH2 Bn), 71.7 (CH2 Bn), 70.5 (C-2), 70.5 (C-5), 69.4 (C-2′), 68.7
(C-5′), 39.1 (Cq), 38.1 (CH2 Lev), 29.9 (CH3 Lev), 28.2 (CH2 Lev),
27.2 (3 × CH3 Piv), 18.2, 17.9 (2 × CH3 C-6, C-6′); HRMS [M +
Na]+ calcd for C51H58F3NO12Na 956.3803, found 956.3809.
Phenyl 3-O-(3,4-Di-O-benzyl-2-O-levulinoyl-α-L-rhamnopyr-
anosyl)-4-O-benzyl-2-O-(3-cyano-2,2-dimethylpropanoyl)-1-
thio-α-L-rhamnopyranoside (18). Imidate donor 14 (4.00 g, 6.51
mmol, 1.1 equiv) and acceptor 16 (2.70 g, 5.92 mmol, 1.0 equiv) were
coevaporated two times with anhydrous toluene under an argon
atmosphere before being dissolved in distilled DCM (59 mL), and the
mixture was stirred at room temperature for 30 min over activated
molecular sieves (3 Å). The reaction was cooled to 0 °C, and TfOH
(0.05 mL, 0.59 mmol, 0.1 equiv) was added. After 50 min, the reaction
was quenched by addition of 1.0 mL of Et3N. The reaction mixture
was diluted with Et2O and washed with saturated aqueous NaHCO3,
H2O, and saturated aqueous NaCl. The organic layer was dried over
MgSO4 and concentrated in vacuo. A quick column purification (PE/
EtOAc, 6:1 → 1:1) followed by crystallization from hot EtOH yielded
the target disaccharide as a white powder (4.57 g, 5.19 mmol, 88%):12
mp 106 °C.
4-O-Benzyl-2-O-(3-cyano-2,2-dimethylpropanoyl)-3-O-(3,4-
di-O-benzyl-2-O-levulinoyl-α-L-rhamnopyranosyl)-α/β-L-rham-
nopyranoside (20). Compound 18 (0.260 g, 0.295 mmol, 1.0 equiv)
was dissolved in acetone/H2O (1.2 mL/0.4 mL) and cooled to 0 °C.
NBS (0.16 g, 0.899 mmol, 3.0 equiv) was added, and the reaction was
stirred for 3 h, after which TLC analysis showed conversion of the
starting material in a lower running spot. The reaction was quenched
by addition of saturated aqueous Na2S2O3 and diluted with EtOAc.
The organic layer was washed with saturated aqueous NaHCO3,
saturated aqueous NaCl, dried over MgSO4, and concentrated in
vacuo. Column purification (PE/EtOAc, 4:1 → 1:1) yielded the
hemiacetal (0.209 g, 0.264 mmol, 89%). Spectroscopic data are
reported for the major (α) isomer: 1H NMR (500 MHz, CDCl3) δ
7.39−7.20 (m, 15H, CHarom), 5.37 (dd, J = 3.0, 1.9 Hz, 1H, H-2′), 5.06
(dd, J = 3.1, 1.9 Hz, 1H, H-2), 5.02 (m, 2H, H-1, H-1′), 4.91 (d, J =
11.2 Hz, 1H, CHH Bn), 4.76 (d, J = 10.9 Hz, 1H, CHH Bn), 4.68−
4.54 (m, 3H, CH2 Bn, CHH Bn), 4.46 (d, J = 11.9 Hz, 1H, CHH Bn),
4.18 (dd, J = 9.5, 3.2 Hz, 1H, H-2), 4.01−3.89 (m, 1H, H-5 or H-5′),
3.77 (dd, J = 9.2, 3.3 Hz, 1H, H-3′), 3.62−3.51 (m, 1H, H-5 or H-5′),
3.39 (m, 2H, H-4, H-4′), 2.78−2.58 (m, 4H, CH2 Lev), 2.58−2.40 (m,
2H, CH2 PivCN), 2.15 (s, 3H, CH3 Lev), 1.37−1.17 (m, 12H, 2 ×
CH3 PivCN, 2 × CH3-6);
13C NMR (126 MHz, CDCl3) δ 206.5 (C
O Lev), 174.3, 171.9 (CO Lev, PivCN), 138.6, 137.9, 137.8 (Cq),
128.6, 128.4, 128.4, 128.0, 128.0, 127.9, 127.8, 127.8, 127.7 (CHarom),
117.4 (CN), 99.8 (C-1′), 91.4 (C-1), 80.3 (C-4 or C-4′), 79.7 (C-4 or
C-4′), 77.0 (C-3′), 76.6 (C-3), 75.6 (CH2 Bn), 75.0 (CH2 Bn), 73.6
(C-2), 71.3 (CH2 Bn), 69.1 (C-2′), 68.5 (C-5 or C-5′), 67.8 (C-5 or
C-5′), 41.0 (Cq), 38.1 (CH2 Lev), 29.9 (CH3 Lev), 29.6 (CH2 Lev),
28.2 (CH2 PivCN), 27.8 (CH2 PivCN), 24.9, 24.8 (2 × CH3 PivCN),
18.1, 17.9 (2 × CH3 C-6, C-6′).
Anomeric PivCN (20a). Compound 18 (3.65 g, 4.15 mmol, 1
equiv) was dissolved in DCM (40 mL) and cooled to 0 °C. NIS (1.03
g, 4.57 mmol, 1.1 equiv) was added followed by the dropwise addition
of TFA (0.35 mL, 4.57 mmol, 1.1 equiv), after which the reaction
turned purple. After 340 min, the reaction was quenched by addition
of 50 mL of saturated aqueous Na2S2O3. The mixture was diluted with
60 mL of DCM and washed with 60 mL of saturated aqueous
NaHCO3. The aqueous layers were extracted 2× with DCM, and the
combined organic layers were washed with saturated aqueous NaCl,
dried over MgSO4, and concentrated in vacuo. Column purification
(PE/EtOAc, 4:1 → 1:1) resulted a mixture of 20 and 20a 73% yield
(2.37 g, 3.01 mmol): Rf 0.35 (PE/EtOAc, 2/1, v/v); IR (neat) 733,
839, 988, 1040, 1063, 1135, 1363, 1454, 1497, 1717, 1737, 2933, 2976;
1H NMR (500 MHz, Chloroform-d) δ 7.41−7.20 (m, 40H), 6.07 (d, J
= 2.2 Hz, 1H), 5.38 (dd, J = 3.3, 1.6 Hz, 3H), 5.13 (t, J = 2.8 Hz, 1H),
5.10−5.05 (m, 3H), 5.05−5.01 (m, 3H), 4.92 (dd, J = 11.2, 2.7 Hz,
3H), 4.81−4.73 (m, 3H), 4.67−4.54 (m, 8H), 4.53−4.43 (m, 3H),
4.18 (dd, J = 9.5, 3.2 Hz, 1H), 4.13 (dd, J = 9.3, 3.3 Hz, 1H), 3.86−
3.72 (m, 4H), 3.63−3.49 (m, 4H), 3.45−3.34 (m, 4H), 2.75−2.60 (m,
11H), 2.56−2.40 (m, 5H), 2.16 (d, J = 2.8 Hz, 8H), 1.37−1.22 (m,
33H); 13C NMR (126 MHz, CDCl3) δ 206.4, 206.3, 173.9, 171.9,
171.9, 155.6, 155.2, 138.0, 138.0, 137.9, 137.9, 137.8, 137.3, 128.7,
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128.7, 128.7, 128.6, 128.6, 128.6, 128.5, 128.5, 128.5, 128.5, 128.5,
128.5, 128.4, 128.4, 128.4, 128.4, 128.4, 128.4, 128.3, 128.3, 128.3,
128.3, 128.2, 128.1, 128.0, 127.9, 127.9, 127.9, 127.9, 127.9, 127.9,
127.8, 127.8, 127.8, 127.8, 127.8, 127.7, 127.7, 127.7, 127.7, 127.7,
127.6, 127.5, 117.8, 117.4, 117.2, 115.4, 113.1, 75.9, 75.8, 75.6, 75.1,
75.1, 74.9, 74.8, 72.1, 71.5, 71.4, 71.4, 71.3, 70.6, 69.7, 69.1, 68.9, 41.1,
41.1, 38.2, 38.1, 38.1, 29.8, 29.7, 28.2, 28.2, 28.2, 28.0, 27.9, 27.8, 27.8,
18.1, 18.1, 18.0; HRMS [M + NH4]
+ calcd for C44H57N2O12 805.3906,
found 805.3908.
4-O-Benzyl-2-O-(3-cyano-2,2-dimethylpropanoyl)-3-O-(3,4-
di-O-benzyl-2-O-levulinoyl-α-L-rhamnopyranosyl)-1-(N-
phenyltrifluoroacetimidoyl)-α/β-L-rhamnopyranoside (2). To a
solution of mixture hemiacetal 20 and 20a (4.15 g, 5.27 mmol, 1
equiv) in acetone (26 mL) at 0 °C were added N-phenyl-
trifluoroacetimidoyl chloride (0.98 mL, 6.32 mmol, 1.2 equiv)
followed by Cs2CO3 (2.57 g, 7.9 mmol, 1.5 equiv). The solution
was allowed to stir overnight, after which it was diluted with EtOAc
and washed subsequently with H2O and saturated aqueous NaCl. The
organic layer was dried over MgSO4 and concentrated in vacuo.
Purification by column chromatography (PE/EtOAc, 6:1 → 1:1)
yielded the title compound as a clear yellow oil (3.98 g, 4.15 mmol,
79%): Rf 0.69 (PE/EtOAc, 2/1, v/v); IR (neat) 751, 1044, 1137, 1119,
1137, 1364, 1453, 1597, 1720, 1741, 2935 cm−1. Spectroscopic data
are reported for the major (α) isomer: 1H NMR (500 MHz, CDCl3) δ
7.39−7.18 (m, 17H, CHarom), 7.12−7.04 (m, 1H, CHarom), 6.83−6.77
(m, 2H, CHarom), 6.00 (s, 1H, H-1), 5.38 (dd, J = 3.3, 1.9 Hz, 1H, H-
2′), 5.24 (dd, J = 3.3, 2.0 Hz, 1H, H-2), 5.06 (d, J = 2.0 Hz, 1H, H-1),
4.90 (d, J = 11.3 Hz, 1H, CHH Bn), 4.79 (d, J = 10.9 Hz, 1H, CHH
Bn), 4.66−4.54 (m, 3H, CHH, CH2 Bn), 4.48 (dd, J = 11.8, 3.2 Hz,
1H, CHH Bn), 4.18 (dd, J = 9.5, 3.2 Hz, 1H, H-3), 3.92−3.81 (m, 1H,
H-5), 3.79 (dd, J = 9.1, 3.4 Hz, 1H, H-3′), 3.67−3.57 (m, 1H, H-5′),
3.53 (t, J = 9.5 Hz, 1H, H-4), 3.41 (t, J = 9.3 Hz, 1H, H-4′), 2.72−2.55
(m, 4H, CH2 Lev), 2.54−2.40 (m, 2H, CH2 PivCN), 2.14 (s, 3H, CH3
Lev), 1.39−1.21 (m, 12H, 2 × CH3 PivCN, 2 × CH3-6); 13C NMR
(126 MHz, CDCl3) δ 205.8 (CO Lev), 173.9, 171.8 (CO Lev,
PivCN), 143.4, 138.8, 138.2, 137.7 (Cq), 128.9, 128.7, 128.6, 128.5,
128.5, 128.4, 128.4, 128.2, 128.1, 128.0, 127.9, 127.8, 127.8, 127.7,
127.7, 124.7, 124.6, 119.5, 119.4, 117.1 (CHarom), 100.0 (C-1′), 93.7
(C-1), 79.9 (C-4), 79.8 (C-4′), 77.3 (C-3′), 76.9 (C-3), 75.8 (CH2
Bn), 75.1 (CH2 Bn), 71.8 (C-2), 71.6 (CH2 Bn), 70.9 (C-5), 69.4 (C-
2′), 68.9 (C-5′), 41.1 (Cq), 38.2 (CH2 Lev), 29.8 (CH3 Lev), 28.4
(CH2 Lev), 28.0 (CH2 PivCN), 25.0, 24.9 (2 × CH3 PivCN), 18.2 (C-
6), 18.0 (C-6′); HRMS [M + NH4]+ calcd C52H61F3N3O12 976.4202,
found 976.4205.
Methods for Automated Synthesis. The washing solvents were
predried 24 h before use on 4 Å molecular sieves and were of HPLC
grade. Activator and deblock solutions were freshly prepared using the
predried solvents. Activator: 0.09 M trifluoromethanesulfonic acid in
DCE. Deblock: 0.12 M hydrazine acetate in pyridine/AcOH (4/1, v/
v).
Method A. Agitation of the resin during washing. After addition
of the appropriate solvent, an argon flow was applied from the bottom
of the RV, suspending the resin in solution. The argon flow was
applied for 15 s, after which the RV was emptied to the waste.
Method B. Agitation of the resin during coupling/deblock. After
addition of the solvent, an argon-flow was applied from the bottom of
the RV for 10 s, suspending the resin in the solution. After 10 s, the
argon flow was interrupted, and the resin was allowed to settle for 20 s.
Method C. Swelling of the resin. Dry resin was applied to the RV
and washed with DCM (3×), alternating THF/hexane (3×), THF
(1×), and DCM (3×).
Method D. Coupling cycle. The resin was suspended in DCM.
The RV was emptied, followed by addition of the building block
solution (1 mL) while being agitated. The delivery line was flushed
with an additional 0.5 mL of DCM to the RV. The temperature was
set to 0 °C while employing method B. A 10 min pause was started,
after which the activator solution (300 μL) was added, keeping the
temperature below 0 °C. The delivery line was flushed with an
additional 0.5 mL of DCM to the RV. Method B was applied for 1 h,
after which the RV was emptied and the mixture was collected in the
fraction collector. The resin was washed with DCM (3 × 2 mL), and
the washes were drained to the fraction collector.
Method E. Deblock cycle. The resin was washed with DMF (4 × 3
mL), running method A. The deblock solution was added (3 mL), and
the temperature was set to 40 °C, followed by a 5 min incubation
applying method B. The temperature was kept at 40 °C, after which
the solid support was incubated 10 min applying protocol B. Then the
RV was emptied to the waste. The resin was washed with DMF (3 × 3
mL), running method A.
Method F. Washing of the resin after coupling. The temperature
was set to 20 °C. The resin was washed with MeOH (3 × 2 mL),
alternating THF/hexane (6 × 2 mL), THF (2 × 2 mL), and DCM (5
× 3 mL), all applying method A.
Method G. Washing of the resin after deblock. The temperature
was set to 20 °C. The resin was washed with DMF (4 × 3 mL), DCM
(4 × 3 mL), alternating THF/hexane (6 × 3 mL), 0.01 M AcOH in
THF (6 × 3 mL), THF (4 × 3 mL), and DCM (8 × 5 mL).
Method H. Suspending the resin for isolation. To the dry resin
was added a mixture of DCM/MeOH (3:2; 5 mL), after which the
resin was agitated for 15 s. The suspended resin was collected from the
RV. The procedure was repeated four times.
Table 1
method
no. of
cycles description time temperature
C 1 swelling of the resin rt
D 1 coupling: 3 equiv of donor,
0.3 equiv of TfOH
60 min 0 °C
E 3 washing of the resin after
coupling
20 °C
F 3 deblock: 8 equiv of H2NNH2·
AcOH
15 min 40 °C
G 1 washing of the resin after
deblock
20 °C
Automated Synthesis of Rhamnose Fragments. The reaction
vessel was charged with carboxy polystyrene 3 (100 mg, 45 μmol), and
method C was applied to prepare the resin for synthesis. Then
methods D and E for coupling and deprotection were repeated 5 times
for decasaccharide 22 and 8 times to obtain hexadecasaccharide 23.
Method H was used to isolate the resin from the reaction vessel. The
resin was dried overnight. After cleavage from the solid support, the
rhamnose fragments were analyzed by LC/MS.
Decarhamnoside (22). The dry resin was charged in a syringe
with a screw cap and suspended in THF/MeOH (2 mL, 1:1) followed
by addition of NaOMe (0.08 mL, 0.54 M NaOMe/MeOH, 1 equiv).
The resin was shaken overnight. The solution was filtered, and the
remaining resin was washed with MeOH (5 × 4 mL). The combined
filtrate and washes were neutralized with 2−3 drops of AcOH and
concentrated in vacuo. The cleavage procedure was repeated once to
obtain the mixture containing 22 as an amorphous solid (0.161 g).
Hexadecarhamnoside (23). The dry resin was charged in a
syringe with a screw cap and suspended in THF/MeOH (2 mL, 1:1)
followed by addition of NaOMe (0.08 mL, 0.54 M NaOMe/MeOH, 1
equiv). The resin was shaken overnight. The solution was filtered, and
the remaining resin was washed with MeOH (5 × 4 mL). The
combined filtrate and washes were neutralized with 2−3 drops of
AcOH and concentrated in vacuo. The cleavage procedure was
repeated once to obtain the mixture containing 23 as an amorphous
solid (0.198 g).
General Procedure for Complete Removal of PivCN Groups.
The crude rhamnoside mixture was dissolved in THF/MeOH (0.6−2
mL, 1:1) and treated with a 0.54 M NaOMe/MeOH (0.7−2 equiv)
solution. The reaction was monitored by LC/MS and allowed to stir
overnight. An additional 0.54 M NaOMe/MeOH was added when
LC/MS analysis indicated incomplete removal of the PivCN groups. If
the deprotection proceeded slowly, the mixture was neutralized,
concentrated in vacuo, and treated with the conditions mentioned vide
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supra. Purification by size exclusion chromatography (LH20, eluted
with DCM/MeOH, 1/1, v/v) or HPLC yielded the target rhamnoside
fragments.
Semiprotected Decarhamnoside (26). The crude rhamnoside
mixture (0.162 g) was dissolved in THF/MeOH (4 mL, 1:1) and
treated with 0.16 mL of NaOMe (0.54 M NaOMe/MeOH). After
overnight stirring, LC/MS analysis indicated incomplete removal of
the PivCN groups, after which the mixture was neutralized with AcOH
and concentrated in vacuo. The mixture was redissolved in THF/
MeOH (2 mL, 1:1), treated with 0.1 mL of NaOMe (0.54 M
NaOMe/MeOH), and stirred overnight. After overnight stirring, 0.08
mL of NaOMe (0.54 M NaOMe/MeOH) was added, followed by 0.16
mL of NaOMe (0.54 M NaOMe/MeOH) after 6.5 h, whereafter LC/
MS analysis indicated complete removal of the PivCN groups. The
mixture was neutralized with AcOH and concentrated in vacuo and
coevaporated once with toluene. The target decarhamnoside was
isolated using RP-HPLC purification (C4 column, gradient 70 → 90,
20 min per run) as a white solid (37.4 mg, 11.8 μmol, 26% based on
45 μmol resin): IR (neat) 736, 1028, 1041, 1070, 1126, 1207, 1361,
1454, 1496, 1681, 2927, 3030, 3377 cm−1; 1H NMR (500 MHz,
MeCN-d3, T = 328 K) δ 7.42−7.18 (m, 84H, CHarom), 5.11−5.06 (m,
4H, CH2 linker-CBz, 2 × H-1), 5.04 (s, 1H, H-1), 4.98 (s, 1H, H-1),
4.87−4.49 (m, 33H), 4.45 (s, 2H, CH2 linker), 4.05−3.95 (m, 8H),
3.95−3.77 (m, 14H), 3.72 (m, 4H), 3.66−3.51 (m, 2H), 3.52−3.34
(m, 9H), 3.32 (s, 1H), 3.21 (t, J = 7.3 Hz, 2H, CH2 linker), 3.06 (s,
5H), 1.53−1.46 (m, 4H, CH2 linker), 1.35−1.24 (m, 7H, CH2 linker,
CH3-6), 1.24−1.11 (m, 17H, CH3-6), 1.10−1.00 (m, 10H, CH3-6);
13C NMR (126 MHz, MeCN-d3, T = 328 K) δ 140.1 (Cq), 129.6,
129.5, 129.5, 129.4, 129.4, 129.3, 129.2, 129.2, 129.1, 129.0, 129.0,
128.8, 128.8, 128.7, 128.7, 128.3, 128.0 (CHarom), 103.2, 103.0, 103.0,
103.0, 102.4, 101.2, 101.0 (10x C-1), 81.5, 81.4, 81.3, 81.2, 81.0, 80.9,
80.8, 80.8, 80.0 (10 × C-3, 10 × C-4), 77.4, 77.3, 77.2 (C-2), 76.1,
76.0, 75.9 (CH2), 72.9, 72.3, 72.2 (CH2), 72.1 (10 × C-2), 69.6, 69.6,
69.3, 69.0, 68.3, 67.8 (10 × C-5), 64.8 (CH2), 51.5 (CH2), 30.1
(CH2), 24.4 (CH2), 18.8, 18.7, 18.7, 18.6 (10 × CH3-6); HRMS [M +
NH4]
+ calcd for C186H221N2O44 3188.5173, found 3188.5121.
Semiprotected Hexadecarhamnoside (29). The crude rhamno-
side mixture (0.199 g) was dissolved in THF/MeOH (2 mL, 1:1) and
treated with 0.10 mL of NaOMe (0.54 M NaOMe/MeOH). After 2 h,
an additional 0.24 mL of NaOMe (0.54 M NaOMe/MeOH) was
added, followed by another 0.10 mL after 4 h. After overnight stirring,
LC/MS analysis indicated complete removal of all PivCN groups, after
which the mixture was neutralized by addition of 2−3 drops AcOH.
The mixture was concentrated in vacuo and coevapotrated with
toluene once. The target hexadecarhamnoside was isolated using RP-
HPLC purification (C4 column, gradient 70→ 90, 20 min per run) as
a white solid (20.3 mg, 4.2 μmol, 9.3% based on 45 μmol resin): IR
(neat) 750, 1051, 1129, 1454, 1671, 2917 cm−1; 1H NMR (600 MHz,
MeCN-d3, T = 328 K) δ 7.39 (d, J = 7.4 Hz, 2H), 7.36−7.17 (m,
129H), 5.12−5.04 (m, 8H), 5.03 (d, J = 1.9 Hz, 1H), 4.97 (d, J = 1.7
Hz, 1H), 4.87−4.47 (m, 60H), 4.44 (s, 2H), 4.08−3.93 (m, 16H),
3.94−3.80 (m, 24H), 3.80−3.63 (m, 8H), 3.63−3.51 (m, 4H), 3.51−
3.34 (m, 16H), 3.33−3.24 (m, 2H), 3.20 (t, J = 7.3 Hz, 2H), 3.17−
2.79 (m, 9H), 1.55−1.43 (m, 4H), 1.36−1.22 (m, 8H), 1.21−1.10 (m,
29H), 1.09−0.95 (m, 21H); 13C NMR (151 MHz, MeCN-d3, T = 328
K) δ 140.1, 140.0, 140.0, 140.0, 129.6, 129.5, 129.4, 129.4, 129.4,
129.3, 129.3, 129.2, 129.1, 129.1, 129.0, 128.9, 128.9, 128.8, 128.7,
128.7, 128.7, 128.6, 128.6, 128.2, 127.9, 118.3, 103.1, 103.0, 102.9,
102.9, 102.9, 102.3, 102.3, 100.9, 81.4, 81.3, 81.3, 81.2, 81.2, 81.1, 81.0,
80.8, 80.7, 79.9, 77.3, 77.3, 77.2, 77.0, 76.0, 75.9, 75.9, 72.8, 72.8, 72.2,
72.1, 72.0, 69.5, 69.5, 69.2, 68.9, 64.7, 51.4, 30.0, 24.3, 18.8, 18.7, 18.6,
18.6, 18.6, 18.5, 1.8, 1.6, 1.5, 1.4, 1.3, 1.2, 1.1, 0.9; MALDI-TOF m/z
[M + Na]+ calcd for C285H331NO68Na 4878.2, found 4884.9.
General Procedure for the Hydrogenation. The oligosacchar-
ide was dissolved in H2O/THF/tBuOH (3:1.3:1.3) followed by
addition of several drops of AcOH. The solution was purged with N2
for 5 min, after which Pd(OH)2/C (10−20 mg) was added followed
by another purge with N2 for 5 min. The solution was purged for 5
min with H2 and kept under a H2 atmosphere overnight. The mixture
was filtered over a Whatmann filter and rinsed with the H2O/THF/
tBuOH mixture and H2O.
Decarhamnoside (5). Compound 26 (19.1 mg, 6 μmol) was
dissolved in H2O/THF/tBuOH (1.6 mL, 3:1.3:1.3), and 4−5 drops of
AcOH were added. The solution was purged with N2 for 5 min, after
which Pd(OH)2/C (20 mg) was added, followed by another purge
with N2 for 5 min. The solution was purged for 5 min with H2 and
kept under a H2 atmosphere overnight. After overnight stirring, the
mixture was filtered through a Whatmann filter and concentrated in
vacuo. Purification by size exclusion chromatography (LH20, eluted
with MeOH/H2O, 9/1,v/v) and analysis by
1H NMR indicated the
presence of aromatic signals. The hydrogenation procedure was
repeated once. Purification using gel filtration (HW-40, eluted with
NH4OAc) and subsequent lyophilization yielded the target decar-
hamnoside as a white powder (5.3 mg, 3.4 μmol, 57%): 1H NMR (500
MHz, D2O) δ 5.11−5.06 (m, 4H), 4.93 (d, J = 1.8 Hz, 1H), 4.87−4.81
(m, 4H), 4.05 (m, 4H), 3.99−3.93 (m, 5H), 3.91−3.87 (m, 1H),
3.86−3.80 (m, 4H), 3.78−3.70 (m, 9H), 3.70−3.56 (m, 8H), 3.49−
3.31 (m, 11H), 2.89 (t, J = 7.6 Hz, 2H), 1.64−1.52 (m, 4H), 1.42−
1.29 (m, 2H), 1.24−1.09 (m, 30H); 13C NMR (126 MHz, D2O) δ
102.5, 102.2, 102.2, 101.0, 101.0, 100.9, 99.7, 78.3, 78.2, 78.1, 77.7,
77.6, 77.6, 72.3, 72.1, 71.9, 71.8, 71.5, 70.3, 70.3, 70.1, 70.1, 70.1, 70.0,
69.5, 69.5, 69.4, 69.3, 68.8, 67.6, 39.5, 28.2, 26.7, 22.8, 22.6, 16.9, 16.8,
16.8, 16.7, 16.6; HRMS [M + H]+ calcd for C65H114NO41 1564.6861,
found 1564.6873.
Hexadecarhamnoside (8). Compound 29 (7.2 mg, 1.5 μmol)
was dissolved in H2O/THF/tBuOH (1.0 mL, 3:1.3:1.3), and 4−5
drops of AcOH were added. The solution was purged with N2 for 5
min, after which Pd(OH)2/C (8 mg) was added, followed by another
purge with N2 for 5 min. The solution was purged for 5 min with H2
and kept under a H2 atmosphere overnight. After overnight stirring,
the mixture was filtered through a Whatmann filter and concentrated
in vacuo. Purification using gel filtration (HW-40, eluted with
NH4OAc) and subsequent lyophilization yielded the target hexade-
carhamnoside as a white powder (1.8 mg, 0.75 μmol, 50%): 1H NMR
(500 MHz, D2O) δ 5.26−5.12 (m, 7H), 5.04 (d, 2H, J = 1.5 Hz), 4.95
(s, 9H), 4.16 (s, 7H), 4.07 (s, 8H), 3.99 (s, 1H), 3.95 (m, 7H), 3.88−
3.68 (m, 25H), 3.59−3.43 (m, 17H), 2.99 (t, 2H, J = 7.5 Hz), 1.74−
1.59 (m, 4H), 1.52−1.39 (m, 2H), 1.35−1.20 (m, 48H); 13C NMR
(126 MHz, D2O) δ 102.4, 102.1, 102.1, 100.9, 100.9, 99.6, 78.2, 78.1,
78.0, 77.6, 77.4, 72.2, 72.0, 71.7, 71.4, 70.2, 70.1, 70.0, 70.0, 69.9, 69.4,
69.4, 69.3, 69.2, 68.7, 67.5, 39.4, 28.1, 26.6, 23.3, 22.5, 16.8, 16.7, 16.7,
16.6, 16.5; HRMS [M + H]+ calcd for C101H174NO65 2442.0369, found
2442.0361.
Isolation of Deletion Fragments. Octarhamnoside (25).
Obtained as byproduct from 22 (10.4 mg, 4.0 μmol): 1H NMR
(500 MHz, MeCN-d3, T = 328 K) δ 7.42−7.37 (m, 2H), 7.36−7.13
(m, 67H), 5.13−5.07 (m, 4H), 5.04 (d, J = 2.1 Hz, 1H), 4.98 (d, J =
1.8 Hz, 1H), 4.88−4.73 (m, 10H), 4.72−4.52 (m, 20H), 4.45 (s, 2H),
4.06−3.96 (m, 7H), 3.95−3.78 (m, 13H), 3.78−3.67 (m, 3H), 3.63−
3.51 (m, 2H), 3.51−3.36 (m, 8H), 3.37−3.28 (m, 1H), 3.22 (t, J = 7.3
Hz, 2H), 3.05 (s, 5H), 1.56−1.44 (m, 4H), 1.30 (s, 6H), 1.24−1.12
(m, 15H), 1.11−1.02 (m, 9H); 13C NMR (126 MHz, MeCN-d3, T =
328 K) δ 140.1, 129.6, 129.6, 129.5, 129.4, 129.4, 129.3, 129.3, 129.2,
129.2, 129.1, 129.1, 129.0, 129.0, 128.9, 128.8, 128.8, 128.7, 128.7,
128.7, 128.6, 128.3, 128.3, 127.9, 111.2, 103.1, 102.9, 102.3, 101.0,
81.4, 81.3, 81.3, 81.3, 81.1, 81.1, 81.0, 80.9, 80.8, 79.9, 77.2, 77.1, 76.1,
75.9, 75.9, 72.8, 72.8, 72.3, 72.1, 72.1, 69.6, 69.5, 69.2, 69.0, 68.2, 67.7,
64.8, 18.8, 18.7, 18.6; HRMS [M + H]+ calcd For C153H180NO36
2608.2246, found 2608.2273.
Deprotected Octarhamnoside (4). White solid after general
hydrogenation procedure (1.35 mg, 1.06 μmol, 69%): 1H NMR
(500 MHz, D2O) δ 5.24−5.13 (m, 3H), 5.03 (s, 1H), 4.94 (s, 3H),
4.15 (s, 3H), 4.06 (s, 4H), 3.98 (s, 1H), 3.97−3.90 (m, 3H), 3.87−
3.66 (m, 14H), 3.60−3.39 (m, 9H), 2.99 (t, J = 7.4 Hz, 2H), 1.76−
1.59 (m, 4H), 1.54−1.37 (m, 2H), 1.36−1.18 (m, 24H); 13C NMR
(126 MHz, D2O) δ 109.8, 102.5, 102.2, 100.9, 99.7, 78.1, 77.6, 72.4,
72.1, 71.9, 71.8, 71.5, 70.3, 70.0, 69.5, 69.4, 69.3, 68.8, 67.6, 59.3, 39.5,
28.2, 26.7, 22.6, 16.8, 16.8, 9.3; HRMS [M + H]+ calcd For
C53H94NO33 1272.5703, found 1272.5714.
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Dodecarhamnoside (27). Obtained as byproduct from 23 (10.3
mg, 2.8 μmol): 1H NMR (600 MHz, MeCN-d3, T = 328 K) δ 7.42−
7.17 (m, 99H), 5.12−5.05 (m, 6H), 5.03 (d, J = 2.1 Hz, 1H), 4.97 (d, J
= 2.0 Hz, 1H), 4.87−4.48 (m, 44H), 4.45 (s, 2H), 4.05−3.94 (m,
12H), 3.93−3.76 (m, 19H), 3.76−3.66 (m, 6H), 3.64−3.51 (m, 3H),
3.50−3.35 (m, 13H), 3.33−3.26 (m, 1H), 3.26 (s, 1H), 3.21 (t, J = 7.3
Hz, 3H), 1.54−1.44 (m, 4H), 1.29 (s, 9H), 1.23−0.98 (m, 36H); 13C
NMR (151 MHz, CD3CN) δ 143.0, 140.3, 140.1, 140.1, 140.0, 140.0,
140.0, 140.0, 139.8, 137.3, 129.6, 129.5, 129.4, 129.4, 129.4, 129.4,
129.4, 129.4, 129.3, 129.3, 129.3, 129.3, 129.2, 129.2, 129.1, 129.1,
129.1, 129.0, 129.0, 129.0, 128.9, 128.8, 128.8, 128.7, 128.7, 128.7,
128.7, 128.6, 128.6, 103.1, 103.0, 102.9, 102.9, 102.9, 102.9, 102.9,
102.3, 102.3, 101.0, 81.4, 81.3, 81.2, 81.2, 81.2, 81.1, 81.0, 80.9, 80.8,
76.1, 76.0, 76.0, 75.9, 75.9, 75.9, 72.8, 72.8, 72.7, 72.2, 69.5, 69.5, 68.2,
67.7, 64.7, 30.0, 27.7, 24.3, 18.7, 18.6, 18.6, 18.6, 18.5; MALDI-TOF
m/z [M + Na]+ calcd for C219H255NO52Na 3753.7, found 3756.4.
Deprotected Dodecarhamnoside (6). White solid after general
hydrogenation procedure (0.51 mg, 0.27 μmol, 27%): 1H NMR (500
MHz, D2O) δ 5.24−5.15 (m, 5H), 5.05−5.00 (m, 1H), 4.94 (s, 6H),
4.14 (d, J = 2.4 Hz, 6H), 4.06 (s, 7H), 3.98 (s, 1H), 3.97−3.88 (m,
7H), 3.87−3.65 (m, 24H), 3.61−3.35 (m, 16H), 3.04−2.93 (m, 2H),
1.76−1.60 (m, 6H), 1.53−1.39 (m, 2H), 1.35−1.18 (m, 36H); HRMS
[M + H]+ calcd for C77H134NO49 1856.8019, found 1856.8064.
Tetradecarhamnoside (28). Obtained as byproduct from 23 (20
mg, 4.65 μmol): 1H NMR (600 MHz, MeCN-d3, T = 328 K) δ 7.48−
7.14 (m, 114H), 5.10−5.05 (m, 6H), 5.03 (d, J = 2.1 Hz, 1H), 4.97 (d,
J = 2.0 Hz, 1H), 4.87−4.48 (m, 46H), 4.45 (s, 2H), 4.06−3.94 (m,
12H), 3.94−3.77 (m, 20H), 3.71 (m, 6H), 3.64−3.50 (m, 3H), 3.50−
3.35 (m, 13H), 3.30 (s, 1H), 3.21 (t, J = 7.3 Hz, 2H), 3.16−3.01 (m,
7H), 1.50 (m, 4H), 1.36−1.24 (m, 5H), 1.24−0.97 (m, 42H); 13C
NMR (151 MHz, CD3CN) δ 140.3, 140.1, 140.1, 140.0, 140.0, 140.0,
140.0, 140.0, 139.8, 137.3, 129.5, 129.5, 129.4, 129.4, 129.4, 129.4,
129.4, 129.3, 129.3, 129.3, 129.2, 129.2, 129.1, 129.1, 129.1, 129.1,
129.0, 129.0, 129.0, 128.8, 128.8, 128.7, 128.7, 128.7, 128.7, 128.7,
128.6, 128.6, 128.6, 103.1, 103.0, 102.9, 102.9, 102.9, 102.9, 102.3,
102.3, 101.0, 81.3, 81.2, 81.2, 81.1, 80.7, 76.1, 76.0, 75.9, 75.9, 75.9,
75.9, 72.8, 72.8, 72.7, 72.2, 72.1, 69.5, 69.5, 68.2, 67.7, 64.7, 30.0, 24.3,
18.6; MALDI-TOF m/z [M + K]+ calcd for C252H293KNO60 4332.0,
found 4337.0.
Deprotected Tetradecarhamnoside (7). White solid after general
hydrogenation procedure (4.7 mg, 2.2 μmol, 92%): 1H NMR (500
MHz, D2O) δ 5.23−5.14 (m, 6H), 5.04 (d, J = 1.7 Hz, 1H), 4.98−4.90
(m, 7H), 4.17−4.13 (m, 6H), 4.07 (s, 7H), 4.02−3.98 (m, 1H), 3.98−
3.90 (m, 7H), 3.89−3.68 (m, 26H), 3.61−3.38 (m, 16H), 3.04−2.95
(m, 2H), 1.77−1.57 (m, 5H), 1.54−1.37 (m, 3H), 1.36−1.18 (m,
42H); 13C NMR (126 MHz, D2O) δ 102.5, 102.1, 100.9, 99.6, 78.1,
78.0, 77.6, 77.4, 72.2, 72.0, 71.8, 71.7, 71.4, 70.2, 70.1, 69.9, 69.4, 69.3,
69.2, 68.7, 67.5, 39.4, 28.1, 26.6, 22.5, 16.8, 16.7, 16.5; HRMS [M +
H]+ calcd For C89H154NO57 2149.9211, found 2149.9220.
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Marel, G. A.; Codeé, J. D. C. Eur. J. Org. Chem. 2016, 2016, 5282−
5293.
(13) Carapetis, J. R.; Steer, A. C.; Mulholland, E. K.; Weber, M.
Lancet Infect. Dis. 2005, 5, 685−694.
(14) Cunningham, M. W. Clin. Microbiol. Rev. 2000, 13, 470−511.
(15) Kabanova, A.; Margarit, I.; Berti, F.; Romano, M. R.; Grandi, G.;
Bensi, G.; Chiarot, E.; Proietti, D.; Swennen, E.; Cappelletti, E.;
Fontani, P.; Casini, D.; Adamo, R.; Pinto, V.; Skibinski, D.; Capo, S.;
Buffi, G.; Gallotta, M.; Christ, W. J.; Campbell, S. A.; Pena, J.;
Seeberger, P. H.; Rappuoli, R.; Costantino, P. Vaccine 2010, 29, 104−
114.
(16) van Sorge, N. M.; Cole, J. N.; Kuipers, K.; Henningham, A.;
Aziz, R. K.; Kasirer-Friede, A.; Lin, L.; Berends, E. T. M.; Davies, M.
R.; Dougan, G.; Zhang, F.; Dahesh, S.; Shaw, L.; Gin, J.; Cunningham,
M.; Merriman, J. A.; Hütter, J.; Lepenies, B.; Rooijakkers, S. H. M.;
Malley, R.; Walker, M. J.; Shattil, S. J.; Schlievert, P. M.; Choudhury,
B.; Nizet, V. Cell Host Microbe 2014, 15, 729−740.
(17) Pozsgay, V.; Jennings, H. J. J. Org. Chem. 1988, 53, 4042−4052.
(18) Dhara, D.; Kar, R. K.; Bhunia, A.; Misra, A. K. Eur. J. Org. Chem.
2014, 2014, 4577−4584.
(19) Hahm, H. S.; Schlegel, M. K.; Hurevich, M.; Eller, S.;
Schuhmacher, F.; Hofmann, J.; Pagel, K.; Seeberger, P. H. Proc.
Natl. Acad. Sci. U. S. A. 2017, 114, E3385−E3389.
(20) Martin, C. E.; Weishaupt, M. W.; Seeberger, P. H. Chem.
Commun. 2011, 47, 10260.
(21) Pozsgay, V. Carbohydr. Res. 1992, 235, 295−302.
(22) Pozsgay, V.; Brisson, J.-R.; Jennings, H. J. Can. J. Chem. 1987,
65, 2764−2769.
(23) Czechura, P.; Guedes, N.; Kopitzki, S.; Vazquez, N.; Martin-
Lomas, M.; Reichardt, N.-C. Chem. Commun. 2011, 47, 2390−2392.
(24) Schmidt and co-workers have described an alternative approach
in which the linker is first attached to the solid support, after which the
remaining free carboxylates on the resin are methylated.
(25) Roussel, F.; Takhi, M.; Schmidt, R. R. J. Org. Chem. 2001, 66,
8540−8548.
The Journal of Organic Chemistry Featured Article
DOI: 10.1021/acs.joc.7b02511
J. Org. Chem. 2017, 82, 12992−13002
13001
(26) Crich, D.; Vinogradova, O. J. Org. Chem. 2007, 72, 3581−3584.
(27) Removal of the anomeric thiophenyl group from 18 was
accompanied by partial migration of the C-2 CNPiv group to the
anomeric position. Upon treatment of the resulting alcohol with the
standard conditions for installation of the imidate group, compound 2
was obtained.
(28) Tesser, G. I.; Balvert-Geers, I. C. Int. J. Pept. Protein Res. 1975, 7,
295−305.
(29) For this synthesis, the reaction time for the glycosylation
reaction was doubled (60 min instead of 30 min), and the amount of
H2NNH2·AcOH used for deprotection of the Lev group was increased
to 8 equiv.
(30) Szpilman, A. M.; Carreira, E. M. Org. Lett. 2009, 11, 1305−1307.
(31) Potter, R. G.; Hughes, T. S. Org. Lett. 2007, 9, 1187−1190.
(32) Huang, F.; Zhang, C.; Li, S.; Zhang, J.; Zhu, K.; Li, N. Org. Lett.
2007, 9, 5553−5556.
The Journal of Organic Chemistry Featured Article
DOI: 10.1021/acs.joc.7b02511
J. Org. Chem. 2017, 82, 12992−13002
13002
